MedTrace Logo

SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes

NCT06926946 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2025-07-23

No results posted yet for this study

Summary

Cerebral oximetry monitoring allows clinicians to optimize blood flow to the brain and oxygenation using the SafeBoosC treatment guideline. The guideline's interventions aims to stabilize blood pressure and oxygen levels.

As low blood pressure is a risk factor for the development of kidney injury, normalizing blood pressure may decrease the incidence of kidney injury in new-borns who are on ventilator.

Conditions

  • Acute Renal Failure
  • Neonatal Morbidity

Interventions

OTHER

Intervention Arm- Cerebral Oximetry + Treatment Guideline

if the cerebral oximeter shows low values, a pre designed treatment guideline will be followed and corrective actions taken.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • St. John's Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2027-06-01
Completion
2027-09-15

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06926946 on ClinicalTrials.gov